Cytokinetics (CYTK) Revenue & Revenue Breakdown
Cytokinetics Revenue Highlights
Latest Revenue (Y)
$7.53M
Latest Revenue (Q)
$249.00K
Main Segment (Y)
Research And Development
Cytokinetics Revenue by Period
Cytokinetics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $7.53M | -92.04% |
| 2022-12-31 | $94.59M | 34.30% |
| 2021-12-31 | $70.43M | 26.15% |
| 2020-12-31 | $55.83M | 107.79% |
| 2019-12-31 | $26.87M | -14.71% |
| 2018-12-31 | $31.50M | 135.64% |
| 2017-12-31 | $13.37M | -87.44% |
| 2016-12-31 | $106.41M | 271.30% |
| 2015-12-31 | $28.66M | -38.95% |
| 2014-12-31 | $46.94M | 53.16% |
| 2013-12-31 | $30.65M | 305.45% |
| 2012-12-31 | $7.56M | 88.97% |
| 2011-12-31 | $4.00M | 55.22% |
| 2010-12-31 | $2.58M | -96.84% |
| 2009-12-31 | $81.54M | 556.51% |
| 2008-12-31 | $12.42M | -8.82% |
| 2007-12-31 | $13.62M | 335.63% |
| 2006-12-31 | $3.13M | -64.91% |
| 2005-12-31 | $8.91M | -33.70% |
| 2004-12-31 | $13.44M | 27.09% |
| 2003-12-31 | $10.58M | -7.19% |
| 2002-12-31 | $11.40M | 34.61% |
| 2001-12-31 | $8.47M | 100.00% |
| 2000-12-31 | - | - |
Cytokinetics generated $7.53M in revenue during NA 2023, up -92.04% compared to the previous quarter, and up 23.90% compared to the same period a year ago.
Cytokinetics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-06-30 | $249.00K | -70.18% |
| 2024-03-31 | $835.00K | -50.06% |
| 2023-12-31 | $1.67M | 342.33% |
| 2023-09-30 | $378.00K | -56.40% |
| 2023-06-30 | $867.00K | -81.21% |
| 2023-03-31 | $4.61M | 135.72% |
| 2022-12-31 | $1.96M | -22.19% |
| 2022-09-30 | $2.52M | -97.17% |
| 2022-06-30 | $88.97M | 7649.83% |
| 2022-03-31 | $1.15M | -97.94% |
| 2021-12-31 | $55.60M | 922.62% |
| 2021-09-30 | $5.44M | 91.24% |
| 2021-06-30 | $2.84M | -56.58% |
| 2021-03-31 | $6.55M | -2.59% |
| 2020-12-31 | $6.72M | -83.88% |
| 2020-09-30 | $41.69M | 1060.26% |
| 2020-06-30 | $3.59M | -6.07% |
| 2020-03-31 | $3.83M | -26.61% |
| 2019-12-31 | $5.21M | -13.92% |
| 2019-09-30 | $6.05M | -15.16% |
| 2019-06-30 | $7.14M | -15.68% |
| 2019-03-31 | $8.46M | -9.74% |
| 2018-12-31 | $9.38M | -11.88% |
| 2018-09-30 | $10.64M | 71.21% |
| 2018-06-30 | $6.21M | 17.98% |
| 2018-03-31 | $5.27M | -29366.67% |
| 2017-12-31 | $-18.00K | -100.29% |
| 2017-09-30 | $6.18M | 102.42% |
| 2017-06-30 | $3.05M | -26.49% |
| 2017-03-31 | $4.15M | -87.47% |
| 2016-12-31 | $33.14M | -43.88% |
| 2016-09-30 | $59.05M | 917.70% |
| 2016-06-30 | $5.80M | -31.10% |
| 2016-03-31 | $8.42M | -13.69% |
| 2015-12-31 | $9.76M | 22.81% |
| 2015-09-30 | $7.95M | 21.45% |
| 2015-06-30 | $6.54M | 48.21% |
| 2015-03-31 | $4.41M | -79.71% |
| 2014-12-31 | $21.76M | 131.10% |
| 2014-09-30 | $9.41M | 20.89% |
| 2014-06-30 | $7.79M | -2.39% |
| 2014-03-31 | $7.98M | -67.23% |
| 2013-12-31 | $24.35M | 444.84% |
| 2013-09-30 | $4.47M | 342.91% |
| 2013-06-30 | $1.01M | 22.90% |
| 2013-03-31 | $821.00K | -62.41% |
| 2012-12-31 | $2.18M | 27.42% |
| 2012-09-30 | $1.71M | -6.90% |
| 2012-06-30 | $1.84M | 1.15% |
| 2012-03-31 | $1.82M | 140.42% |
| 2011-12-31 | $757.00K | -46.95% |
| 2011-09-30 | $1.43M | 35.52% |
| 2011-06-30 | $1.05M | 38.01% |
| 2011-03-31 | $763.00K | -30.57% |
| 2010-12-31 | $1.10M | 178.93% |
| 2010-09-30 | $394.00K | -14.72% |
| 2010-06-30 | $462.00K | -25.60% |
| 2010-03-31 | $621.00K | -39.30% |
| 2009-12-31 | $1.02M | -81.42% |
| 2009-09-30 | $5.51M | -92.35% |
| 2009-06-30 | $71.93M | 2236.91% |
| 2009-03-31 | $3.08M | -2.35% |
| 2008-12-31 | $3.15M | 0.86% |
| 2008-09-30 | $3.13M | 1.66% |
| 2008-06-30 | $3.07M | 0.16% |
| 2008-03-31 | $3.07M | -1.32% |
| 2007-12-31 | $3.11M | - |
Cytokinetics generated $249.00K in revenue during Q2 2024, up -70.18% compared to the previous quarter, and up 5.40% compared to the same period a year ago.
Cytokinetics Revenue Breakdown
Cytokinetics Revenue Breakdown by Product
Annual Revenue by Product
| Product/Service | Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 |
|---|---|---|---|---|---|
| Research And Development | $4.03M | $6.59M | $10.57M | $16.53M | - |
| License | - | - | $36.50M | - | - |
| Milestone | $3.50M | $1.00M | - | - | - |
| Research And Development Milestone Grant And Other Revenues Net | - | - | $7.40M | $10.00M | $13.80M |
| Reimbursements | - | - | - | - | $13.11M |
| Milestone Fees | - | - | - | - | - |
Cytokinetics's latest annual revenue breakdown by segment (product or service), as of Dec 23: Research And Development (53.52%), and Milestone (46.48%).
Quarterly Revenue by Product
| Product/Service | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Milestone | - | $1.00M | - | - | $2.50M | - | - | $1.00M | - | - | - | - | - | - | - | - | - | - | - | - |
| Research And Development | $835.00K | $672.00K | $378.00K | $867.00K | $2.11M | $1.96M | $2.52M | $968.00K | $1.15M | $744.00K | $437.00K | $2.84M | $6.55M | $3.92M | $5.19M | $3.59M | $3.83M | $5.21M | $6.05M | $7.14M |
| License | - | - | - | - | - | - | - | - | - | $54.86M | - | - | - | - | - | - | - | - | - | - |
| Milestones | - | - | - | - | - | - | - | - | - | - | $5.00M | - | - | - | - | - | - | - | - | - |
| Research And Development Milestone Grant And Other Revenues Net | - | - | - | - | - | - | - | - | - | - | - | $2.50M | $4.80M | $1.70M | $3.80M | $2.10M | $2.30M | - | - | - |
Cytokinetics's latest quarterly revenue breakdown by segment (product or service), as of Mar 24: Research And Development (100.00%).
Cytokinetics Revenue Breakdown by Country
Quarterly Revenue by Country
| Country | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | Jun 19 | Mar 19 | Sep 18 | Jun 18 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Milestone | - | $2.50M | - | - | $1.00M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Research And Development | $867.00K | $2.11M | $1.96M | $2.52M | $968.00K | $1.15M | $744.00K | $437.00K | $2.84M | $6.55M | $3.92M | $5.19M | $3.59M | $3.83M | $5.21M | $6.05M | $7.14M | $8.46M | - | - |
| License | - | - | - | - | - | - | $54.86M | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Milestones | - | - | - | - | - | - | - | $5.00M | - | - | - | - | - | - | - | - | - | - | - | - |
| Research And Development Milestone Grant And Other Revenues Net | - | - | - | - | - | - | - | - | $2.50M | $4.80M | $1.70M | $3.80M | $2.10M | $2.30M | - | - | - | - | - | - |
| License And Service | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | $1.92M | $1.53M |
Cytokinetics's latest quarterly revenue breakdown by geography, as of Jun 23: Research And Development (100.00%).
Cytokinetics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| AMLX | Amylyx Pharmaceuticals | $380.79M | $88.64M |
| BPMC | Blueprint Medicines | $249.38M | $138.16M |
| ARVN | Arvinas | $78.50M | $76.50M |
| RLAY | Relay Therapeutics | $25.55M | - |
| RVMD | Revolution Medicines | $11.58M | - |
| STOK | Stoke Therapeutics | $8.78M | $4.22M |
| CYTK | Cytokinetics | $7.53M | $249.00K |
| PLRX | Pliant Therapeutics | $1.58M | - |
| KRTX | Karuna Therapeutics | $654.00K | - |
| BDTX | Black Diamond Therapeutics | - | - |
| XFOR | X4 Pharmaceuticals | - | $563.00K |
| DICE | DICE Therapeutics | - | - |
| ABOS | Acumen Pharmaceuticals | - | - |
| INZY | Inozyme Pharma | - | - |
| DYN | Dyne Therapeutics | - | - |
| TERN | Terns Pharmaceuticals | - | - |
| EWTX | Edgewise Therapeutics | - | - |
CYTK Revenue FAQ
What is Cytokinetics’s yearly revenue?
Cytokinetics's yearly revenue for 2023 was $7.53M, representing a decrease of -92.04% compared to 2022. The company's yearly revenue for 2022 was $94.59M, representing an increase of 34.30% compared to 2021. CYTK's yearly revenue for 2021 was $70.43M, representing an increase of 26.15% compared to 2020.
What is Cytokinetics’s quarterly revenue?
Cytokinetics's quarterly revenue for Q2 2024 was $249K, a -70.18% decrease from the previous quarter (Q1 2024), and a -71.28% decrease year-over-year (Q2 2023). The company's quarterly revenue for Q1 2024 was $835K, a -50.06% decrease from the previous quarter (Q4 2023), and a -81.90% decrease year-over-year (Q1 2023). CYTK's quarterly revenue for Q4 2023 was $1.67M, a 342.33% increase from the previous quarter (Q3 2023), and a -14.56% decrease year-over-year (Q4 2022).
What is Cytokinetics’s revenue growth rate?
Cytokinetics's revenue growth rate for the last 3 years (2021-2023) was -89.31%, and for the last 5 years (2019-2023) was -71.97%.
What are Cytokinetics’s revenue streams?
Cytokinetics's revenue streams in c 23 are Research And Development, and Milestone. Research And Development generated $4.03M in revenue, accounting 53.52% of the company's total revenue, down -38.83% year-over-year. Milestone generated $3.5M in revenue, accounting 46.48% of the company's total revenue, up 250.00% year-over-year.
What is Cytokinetics’s main source of revenue?
For the fiscal year ending Dec 23, the largest source of revenue of Cytokinetics was Research And Development. This segment made a revenue of $4.03M, representing 53.52% of the company's total revenue.